Aroxxen

· Research Institute of Geroprotective Technologies

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aroxxen, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Aroxxen® Inhalation for Cardioprotection After Elective PCI With Stent Implantation [Phase 2]